Lorenzo Falsetti, Emanuele Guerrieri, Vincenzo Zaccone, Giovanna Viticchi, Silvia Santini, Laura Giovenali, Graziana Lagonigro, Stella Carletti, Linda Elena Gialluca Palma, Nicola Tarquinio, Gianluca Moroncini
Pulmonary embolism (PE) is a potentially life-threatening condition requiring prompt diagnosis and treatment. Recent advances have led to the development of newer techniques and drugs aimed at improving PE management, reducing its associated morbidity and mortality and the complications related to anticoagulation. This review provides an overview of the current knowledge and future perspectives on PE treatment. Anticoagulation represents the first-line treatment of hemodynamically stable PE, direct oral anticoagulants being a safe and effective alternative to traditional anticoagulation: these drugs have a rapid onset of action, predictable pharmacokinetics, and low bleeding risk...
March 28, 2024: Journal of Clinical Medicine